South Korean medical software application designer Medical IP transfer to AWS cloud

Medical imaging services business Medical IP from South Korea has actually participated in a brand-new collaboration with Amazon Web Services to boost its digital change.

They signed a letter of assistance where they concurred Medical IP will move to the AWS cloud, beginning with its flagship item, x– ray division and quantitative analysis option TiSepX, MEDIP PRO digital twin application service and visual printing innovation.

Through their partnership, Medical IP will utilize AWS’s HIPAA-eligible information management service Amazon HealthLake in its cloud-native APIs. According to the business, it runs its medical imaging apps utilizing a single, reliable copy of information without developing numerous image information in the cloud, conserving the expenses of keeping medical images. Utilizing AWS HealthLake, its apps will have the ability to perform faster image searches and quicken research study.

The business will likewise deal with AWS to establish a digital twin platform that can turn medical images into digital representations of physical items without limitations in time and area utilizing medical image-based AI division and 3D application innovation.

Additionally, Medical IP prepares to utilize AWS’s worldwide cloud facilities and services to establish a cloud-based medical image analysis platform optimised for worldwide clients, consisting of those in the United States, China and the Middle East, enhancing its global competitiveness.


By moving to the AWS cloud, Medical IP’s innovation is anticipated to “get rid of restrictions”; its medical image-based innovation can now be released for multi-institutional joint research study and real-time interactions in between organizations, going beyond even geographical borders. Relying on the AWS cloud will likewise aid with Medical IP’s smooth conduct of multi-institutional medical trials for its medical imaging services.

Ultimately, this cloud migration offers Medical IP an one-upmanship in the worldwide medical imaging analytics software application market, which was forecasted to be worth almost $ 4.3 billion by 2025, according to Statista.


Their cooperation started in 2021 when Medical IP signed up with the AWS Diagnostic Development Initiative, which looked for to assist organisations use cloud innovation to speed up diagnostics R&D. Through that extremely program, the TiSepX was borne. Powered by AWS AI and ML services, the software application option assesses the seriousness of COVID-19 on chest x-ray images.

Earlier this month, Medical IP got the approval southern Korean Ministry of Food and Drug Safety for TiSepX. The business is working to get more abroad clearances for its software and look for partners to embrace its innovation. It is likewise set to start medical trials for TiSepX in New York as part of its application for a United States Food and Drug Administration market approval.


” Healthcare AI and the cloud are essential innovations that can accelerate our journey in establishing health care options. AWS’s assistance will work as a foundation for Medical IP’s acknowledgment and growth into the worldwide market,” stated Sang Joon Park, CEO of MEDICAL IP.

Leave a Reply

Your email address will not be published.